Decreased mRNA and protein expression of TWIST1 in myocardial tissue of fetuses with ventricular septal defects

Wang,Yuting; Wang,Qidi; Guo,Changlong; Wang,Shuo; Qiu,Yue; Li,Hui; Ma,Xu

doi:10.3892/mmr.2015.3734

Decreased mRNA and protein expression of TWIST1 in myocardial tissue of fetuses with ventricular septal defects

Authors:
- Yuting Wang
- Qidi Wang
- Changlong Guo
- Shuo Wang
- Yue Qiu
- Hui Li
- Xu Ma
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Genetics, National Research Institute for Family Planning, Beijing 100081, P.R. China
Published online on: May 6, 2015 https://doi.org/10.3892/mmr.2015.3734
Pages: 3089-3094

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ventricular septal defect (VSD) is the most common type of congenital heart disease (CHD). The single gene mutations or absences that contribute to VSD development are well established; however, the aim of the present study was to measure gene expression variation between VSDs and normal fetal myocardial tissue. TWIST1, an important tumor biomarker, is a basic helix‑loop‑helix transcription factor that regulates cell proliferation, migration and differentiation in embryonic development and transformed tumor cells. Although growing evidence demonstrates that TWIST1 participates in a variety of human neoplastic diseases, the role of TWIST1 in VSD has remained elusive. Twenty‑six VSD fetal myocardial tissue samples and 12 normal samples at matched gestational weeks (22‑28 weeks) were included in the present study. Using reverse transcription quantitative polymerase chain reaction (PCR) and real‑time PCR, it was demonstrated that TWIST1 mRNA was reduced by almost two‑fold in the VSD samples compared with the normal samples. Western blot analysis also revealed that TWIST1 expression was decreased by ~three‑fold (P=0.001) in the VSD samples compared with that in the normal samples. Of note, five complete ventricular (also called functionally univentricular or single ventricular) septal ageneses were identified among the specimens. For the five complete ventricular septal agenesis samples, similar results to those for other VSD fetal myocardial tissues were obtained. In conclusion, the results of the present study showed that TWIST1 mRNA and protein levels were reduced in VSDs. The present study was the first, to the best of our knowledge, to report that TWIST1 is not only a tumor biomarker, but may also be involved in the pathogenesis of VSD.

View Figures

View References

1	Go AS, Mozaffarian D, Roger VL, et al: Heart disease and stroke statistics-2013 update: a report from the American heart association. Circulation. 127:e6–e245. 2013. View Article : Google Scholar
2	Hoffman JI: Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol. 16:103–113. 1995. View Article : Google Scholar : PubMed/NCBI
3	Hoffman JI and Kaplan S: The incidence of congenital heart disease. J Am Coll Cardiol. 39:1890–1900. 2002. View Article : Google Scholar : PubMed/NCBI
4	Misra C, Sachan N, McNally CR, et al: Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo. PLoS Genet. 8:e10026902012. View Article : Google Scholar : PubMed/NCBI
5	Xuan C, Jia KG, Wang BB, et al: Identification of two novel mutations of the HOMEZ gene in Chinese patients with isolated ventricular septal defect. Genet Test Mol Biomarkers. 17:390–394. 2013. View Article : Google Scholar : PubMed/NCBI
6	Jenkins KJ, Correa A, Feinstein JA, et al: Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American heart association council on cardiovascular disease in the young: endorsed by the American academy of pediatrics. Circulation. 115:2995–3014. 2007. View Article : Google Scholar : PubMed/NCBI
7	Pierpont ME, Basson CT, Benson DW Jr, et al: Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American heart association congenital cardiac defects committee, council on cardiovascular disease in the young: endorsed by the american academy of pediatrics. Circulation. 115:3015–3038. 2007. View Article : Google Scholar : PubMed/NCBI
8	Conway SJ, Firulli B and Firulli AB: A bHLH code for cardiac morphogenesis. Pediatr Cardiol. 31:318–324. 2010. View Article : Google Scholar :
9	Castanon I and Baylies MK: A Twist in fate: evolutionary comparison of Twist structure and function. Gene. 287:11–22. 2002. View Article : Google Scholar : PubMed/NCBI
10	Shelton EL and Yutzey KE: Twist1 function in endocardial cushion cell proliferation, migration and differentiation during heart valve development. Dev Biol. 317:282–295. 2008. View Article : Google Scholar : PubMed/NCBI
11	Vincentz JW, Barnes RM, Rodgers R, Firulli BA, Conway SJ and Firulli AB: An absence of Twist1 results in aberrant cardiac neural crest morphogenesis. Dev Biol. 320:131–139. 2008. View Article : Google Scholar : PubMed/NCBI
12	Wang X, Ling MT, Guan XY, et al: Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene. 23:474–482. 2004. View Article : Google Scholar : PubMed/NCBI
13	Yang J, Mani SA, Donaher JL, et al: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
14	Yang J, Mani SA and Weinberg RA: Exploring a new twist on tumor metastasis. Cancer Res. 66:4549–4552. 2006. View Article : Google Scholar : PubMed/NCBI
15	Rajagopal SK, Ma Q, Obler D, et al: Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol. 43:677–685. 2007. View Article : Google Scholar : PubMed/NCBI
16	Garg V: Insights into the genetic basis of congenital heart disease. Cell Mol Life Sci. 63:1141–1148. 2006. View Article : Google Scholar : PubMed/NCBI
17	Mori AD and Bruneau BG: TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol. 19:211–215. 2004. View Article : Google Scholar : PubMed/NCBI
18	Biben C, Weber R, Kesteven S, et al: Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2–5. Circ Res. 87:888–895. 2000. View Article : Google Scholar : PubMed/NCBI
19	Huber J, Peres VC, de Castro AL, et al: Molecular screening for 22Q11.2 deletion syndrome in patients with congenital heart disease. Pediatr Cardiol. 35:1356–1362. 2014. View Article : Google Scholar : PubMed/NCBI
20	Tan M, Xu C, Sim SK, Seow AL, Tan TH and Quek SC: Types and distribution of congenital heart defects associated with trisomy 21 in Singapore. J Paediatr Child Health. 49:223–227. 2013. View Article : Google Scholar : PubMed/NCBI
21	Bruneau BG: The developmental genetics of congenital heart disease. Nature. 451:943–948. 2008. View Article : Google Scholar : PubMed/NCBI
22	Verheugt CL, Uiterwaal CS, van der Velde ET, et al: The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 96:872–878. 2010. View Article : Google Scholar : PubMed/NCBI
23	Zhu C, Yu ZB, Chen XH, et al: Screening for differential methylation status in fetal myocardial tissue samples with ventricular septal defects by promoter methylation microarrays. Mol Med Rep. 4:137–143. 2011.PubMed/NCBI
24	Soto B, Becker AE, Moulaert AJ, Lie JT and Anderson RH: Classification of ventricular septal defects. Br Heart J. 43:332–343. 1980. View Article : Google Scholar : PubMed/NCBI
25	Zhao QM, Ma XJ, Jia B and Huang GY: Prevalence of congenital heart disease at live birth: an accurate assessment by echocardio-graphic screening. Acta Paediatr. 102:397–402. 2013. View Article : Google Scholar : PubMed/NCBI
26	Sands AJ, Casey FA, Craig BG, Dornan JC, Rogers J and Mulholland HC: Incidence and risk factors for ventricular septal defect in ‘low risk’ neonates. Arch Dis Child Fetal Neonatal Ed. 81:F61–F63. 1999. View Article : Google Scholar : PubMed/NCBI
27	Yang Z, Li XJ, Luo T and Wu XT: Expression of TWIST in gastric carcinoma and its correlation with clinical significance. Sichuan Da Xue Xue Bao Yi Xue Ban. 42:625–629. 2011.In Chinese. PubMed/NCBI
28	Gort EH, Suijkerbuijk KP, Roothaan SM, et al: Methylation of the TWIST1 promoter, TWIST1 mRNA levels and immunohistochemical expression of TWIST1 in breast cancer. Cancer Epidemiol Biomarkers Prev. 17:3325–3330. 2008. View Article : Google Scholar : PubMed/NCBI
29	Ohuchida K, Mizumoto K, Ohhashi S, et al: Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer. 120:1634–1640. 2007. View Article : Google Scholar : PubMed/NCBI
30	Yuen HF, Chan YP, Wong ML, et al: Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J Clin Pathol. 60:510–514. 2007. View Article : Google Scholar
31	Valdés-Mora F, Gómez del Pulgar T, Bandrés E, et al: TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer. Ann Surg Oncol. 16:78–87. 2009. View Article : Google Scholar
32	Barnes RM and Firulli AB: A twist of insight-the role of Twist-family bHLH factors in development. Int J Dev Biol. 53:909–924. 2009. View Article : Google Scholar :
33	Lu S, Nie J, Luan Q, et al: Phosphorylation of the Twist1-family basic helix-loop-helix transcription factors is involved in pathological cardiac remodeling. PLoS One. 6:e192512011. View Article : Google Scholar : PubMed/NCBI
34	Wirrig EE and Yutzey KE: Conserved transcriptional regulatory mechanisms in aortic valve development and disease. Arterioscler Thromb Vasc Biol. 34:737–741. 2014. View Article : Google Scholar : PubMed/NCBI
35	Vrljicak P, Cullum R, Xu E, et al: Twist1 transcriptional targets in the developing atrio-ventricular canal of the mouse. PLoS One. 7:e408152012. View Article : Google Scholar : PubMed/NCBI
36	Lee MP and Yutzey KE: Twist1 directly regulates genes that promote cell proliferation and migration in developing heart valves. PLoS One. 6:e297582011. View Article : Google Scholar
37	Chakraborty S, Wirrig EE, Hinton RB, Merrill WH, Spicer DB and Yutzey KE: Twist1 promotes heart valve cell proliferation and extracellular matrix gene expression during development in vivo and is expressed in human diseased aortic valves. Dev Biol. 347:167–179. 2010. View Article : Google Scholar : PubMed/NCBI
38	Firulli BA, McConville DP, Byers JS III, Vincentz JW, Barnes RM and Firulli AB: Analysis of a Hand1 hypomorphic allele reveals a critical threshold for embryonic viability. Dev Dyn. 239:2748–2760. 2010. View Article : Google Scholar : PubMed/NCBI
39	Quach N, Goodman MF and Shibata D: In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during PCR. BMC Clin Pathol. 4:12004. View Article : Google Scholar : PubMed/NCBI
40	Johnson B and Simpson LL: Screening for congenital heart disease: a move toward earlier echocardiography. Am J Perinatol. 24:449–456. 2007. View Article : Google Scholar : PubMed/NCBI